Hepcinat LP Ledipasvir plus Sofosbuvir tablets

Natco Pharma has launched the first generic version of Sofosbuvir and Ledipasvir under the brand name Hepcinat LP. It is a fixed-dose combination drug that contains 400 mg of Sofosbuvir and 90 mg of Ledipasvir in a single tablet.

Hepcinat LP is a prescription medication used to treat hepatitis C virus infection. Based on research, the sofosbuvir-based regimen gives a higher cure rate with fewer side effects. The medicine allows more patients to deal effectively with Hepatitis C without utilising peg interferon, an infused medication with serious side effects. This is the most effective blend for treating HCV. The combination medicine is used for the treatment of chronic hepatitis C, specifically genotypes 1, 2, 3, and 4, in conjunction with pegylated interferon and ribavirin, or ribavirin alone.

Hepcinat LP uses

Hepcinat LP is especially effective in treating chronic hepatitis C virus infection. The medicine helps to prevent the growth and spread of the virus in the body. The combination fixed-dose medicine can also be prescribed to treat patients with hepatocellular carcinoma and hepatitis C, who have decided to go for liver transplantation to prevent the recurrence of the infection.

Side effects

It is essential to inform your physician of any symptoms that occur while taking Ledipasvir and Sofosbuvir tablets. Individuals taking Hepcinat LP may experience headaches, decreased appetite, sleep disturbances, and an itchy sensation. Consult your physician if any of these symptoms persist or trouble you for an extended period. Patients taking this hepatitis C medication may also experience some serious side effects. These include hives, behavioural deviations, irregular heartbeat, swallowing trouble, breathing problems, and indications of any infection.

Dosing information

Hepcinat LP should be taken as a single daily dose. It is to be swallowed with a glass full of water. It must be taken under the supervision of an experienced medical practitioner. Depending upon the size of the liver damage, the treatment period may vary between 12 to 24 weeks.

Special precautions

Tell your physician if you are allergic to Ledipasvir or Sofosbuvir, or any other ingredient of the medication present in the combination drug. You must tell your physician what other prescription and non-prescription medications, nutritional supplements, and other herbal products you are taking or planning to purchase. If you are told to consume antacids containing aluminium hydroxide or magnesium hydroxide, take them four hours after taking your hepatitis C medication. Tell your physician if you have or ever had any renal insufficiency or hepatic impairment other than hepatitis C. Inform your physician about your pregnancy status or if you are a nursing mother. If you become pregnant during the hepatitis C infection, talk to your physician.

Other information

Remember all your appointments with your physician. Your physician may recommend certain clinical tests to assess your body’s response to Hepcinat LP. Don’t let anyone take your hepatitis C drug. Ask your physician or pharmacist if you have any questions about refilling the prescription. Let the tablets be in the original container they came in, and tightly close it whenever you take out your dose. Keep these tablets away from the reach of children.  Do not use it if the seal is broken. Store it at room temperature.